Back to state act
Description
On 8 January 2026, Johnson & Johnson announced reaching an agreement with the U.S. Administration. Under the agreement, Johnson & Johnson's pharmaceutical products will be exempt from potentia...
Sign in to see full description
Intervention Details
Intervention Type
Tax or social insurance relief
MAST Chapter
L: Subsidies (excl. export subsidies)
Implementation date
No implementation date
Revocation date
No revocation date
Implementation level
National
Affected flow
Inward
Announced as temporary
No
Eligible firms
firm-specific
Affected Trading Partners
Table
Affected Sectors
Sign in to access 1 sectors
Affected Products
Sign in to access 5 products
Threads
See all
This intervention is not part of any Thread yet.